Epidiolex Cannabidiol Bottle

EPIDIOLEX®
(cannabidiol) Cannabidiol CV Symbol
is a first-in-class AED1

Chemical Structure Icon

Structurally distinct from other AEDs2

Drug Efficacy Icon

Believed to exert its anticonvulsant effects through multiple modes of action2

The precise mechanisms by which EPIDIOLEX exerts its anticonvulsant effect in humans are unknown. However, EPIDIOLEX does not appear to exert its anticonvulsant effects through interaction with cannabinoid receptors.2

Epidiolex Cannabidiol Bottle

The first and only
FDA-approved
prescription cannabidiol1

Funnel Icon

Quality standards

Meets FDA standards to ensure consistent batch-to-batch concentrations of cannabidiol and a stable shelf life2,3

Congress Icon

Approved
Schedule V drug

Federally legal and can be prescribed nationwide by healthcare professionals2

Health Insurance Icon

Coverage

Eligible for insurance coverage for appropriate patients, with prescriptions filled by specialty pharmacies and licensed pharmacists


Efficacy, safety profile, and dosing established across multiple controlled studies2

VIEW EFFICACY
VIEW SAFETY

EPIDIOLEX was evaluated in the largest pivotal clinical trial program (N=516) for both LGS and Dravet syndrome to date2-4

SEE BASELINE DEMOGRAPHICS

References: 1. Food and Drug Administration website. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611046.htm. Accessed June 29, 2018. 2. EPIDIOLEX [package insert]. Carlsbad, CA: Greenwich Biosciences, Inc.; 2018. 3. Data on file. Greenwich Biosciences, Inc., Carlsbad, CA. 4. Ostendorf AP, Ng YT. Neuropsychiatr Dis Treat. 2017;13:1131-1140.